Supply Chain | July 16, 2022
India Health Link join hands with Canopi
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
Mittal will be driving expansion of the provider network across India
Advancing to IND-enabling studies with multiple drug candidates
This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
Novavax’ clinical development program reported no severe allergic reactions
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
Subscribe To Our Newsletter & Stay Updated
